LivingGLP1
Study S000849

Investigating Brain PLASTICity and GLP-1 Receptor Agonists in the Treatment of Obesity: The PLASTIC Trial

ClinicalTrials.gov record

Registration

Registration
NCT07021937
Acronym
PLASTIC
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE3
Masking
QUADRUPLE
Status
NOT_YET_RECRUITING
Enrollment
120
Start
2026-06-15
Primary completion
2031-04-30
Lead sponsor
University of Colorado, Denver
Conditions
Obesity/Therapy
Interventions
DRUG:Semaglutide 1.7mg subcutaneous; DRUG:Placebo
Results posted
FALSE
Individual participant data sharing
NO
Secondary identifiers
OTHER:Pending

Registered primary outcomes

  • blood oxygen-level dependent signal [From enrollment to the end of trial at 32 weeks]
  • meal kilocalories (kcal) [From enrollment to the end of trial at 32 weeks]
  • visual analogue scale (VAS) score for hunger [From enrollment to the end of trial at 32 weeks]
  • visual analogue scale (VAS) for desire to eat [From enrollment to end of trial at 32 weeks]
  • visual analogue scale (VAS) score for fullness [From enrollment to end of trial at 32 weeks]
  • visual analogue scale (VAS) score for amount participant feels they can eat [From enrollment to end of trial at 32 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.